Explore
Companies
Investors
Top 50
Streams
Trending tech news
Latest investments
Latest acquisitions
About Index
Index
By TNW
Log in
Register
Fractyl Labs
3150
Fractyl Labs
Health Care
Medical
Medical Devices
Developing an Innovative Endoscopic Outpatient Procedure to Improve Glycemic Control for Type 2 Diabetes
Suggest edits
Founded
2011
Raised
$182.3M
Follow us
Companies in the same industry
ivWatch
Evasc Neurovascular Enterprises
Riablo by CoRehab
CorAssist Cardiovascular Ltd.
Go Healthy Next
OrthAlign, Inc.
Perceive3D
Ortho Sales Partners
Surgify
Turner Imaging Systems
Alexa global traffic share
Twitter followers
Overview
Funding
5
Add info
Latest funding
Show all
$44,000,000
Venture capital (Series D) - 2017
Bessemer Venture Partners
Deerfield Management Company
General Catalyst Partners
+6
$47,170,000
Venture capital - 2016
Team Size
10+
Employees
I work here
Location
United States
Headquarters
Explore United States
Fractyl Labs, 44 millions de dollars pour lutter contre le diabète
$44,000,000
Venture capital (Series D)
TechCrunch
Fractyl Labs raises $44 million in Series D to develop a treatment for type 2 diabetes
Health
Funding
$57,000,000
Venture capital (Series C)
Added by
via
BioPortfolio
Fractyl Announces Completion of $57 Million Series C Investment
$19,760,000
Venture capital (Series B)
Added by
via
TechCrunch
Fractyl Labs Raises $40M Series C To Develop Diabetes Treatments
